Sequential Therapy in Multiple Myeloma Guided by MRD Assessments
Sequential Therapy in Multiple Myeloma Guided by MRD Assessments
Active, not recruiting · NCT05231629 · Registry updated 2026-09-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Sequential Therapy in Multiple Myeloma Guided by MRD Assessments | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Active, not recruiting | Phase 2 | 2026-09-22 | NCT05231629 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| coMMit, Myeloma Trials, Innovated | 2 |
| Janssen Scientific Affairs, LLC | 37 |
| Sarah Cannon | 1 |
| University of Alabama at Birmingham | 467 |
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Colorado Blood Cancer Institute | Denver | United States | 178 |
| Columbia University | New York | United States | 154 |
| Medical College of Wisconsin | Milwaukee | United States | 483 |
| Oregon Health and Science University | Portland | United States | 382 |
| University of Alabama at Birmingham | Birmingham | United States | 193 |
| University of Texas Southwestern | Dallas | United States | 73 |
| University of Utah | Salt Lake City | United States | 137 |
| University of Washington | Seattle | United States | 36 |
| University of Wisconsin - Carbone | Madison | United States | 1 |
| Vanderbilt University | Nashville | United States | 51 |